Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial
Keywords: استنت سم زدایی; Bare metal stent; STEMI; Drug-eluting stent;
مقالات ISI استنت سم زدایی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Maintenance of Drug-Eluting Stent Patency Through Use of a Cangrelor Infusion in the Clinical Setting of Massive Pulmonary Hemorrhage and Venoarterial Extracorporeal Membrane Oxygenation
Keywords: استنت سم زدایی; drug-eluting stent; pulmonary hemorrhage; stent patency; venoarterial membrane oxygenation;
Mechanical abnormalities associated with first- and second-generation drug-eluting stent thrombosis analyzed by optical coherence tomography in the national PESTO French registry
Keywords: استنت سم زدایی; Stent thrombosis; Drug-eluting stent; Intracoronary imaging; Neoatherosclerosis;
Zotarolimus-eluting Resolute Integrity versus everolimus-eluting Xience Xpedition stents in the management of very long (>30Â mm) de novo coronary artery stenosis
Keywords: استنت سم زدایی; Coronary lesion; De novo; Drug-eluting stent; Long segment;
The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry)
Keywords: استنت سم زدایی; ACC; American College of Cardiology; ACS; Acute coronary syndrome; AHA; American Heart Association; CABG; Coronary artery bypass graft; CK-MB; Creatine kinase-MB fraction; CTO; Chronic total occlusion; DES; Drug-eluting stent; DM; Diabetes mellitus; EeCCS
ClinicalBIOFLOW-III satellite-One-year clinical outcomes of diabetic patients treated with a biodegradable polymer sirolimus-eluting stent and comprehensive medical surveillanceâ
Keywords: استنت سم زدایی; Drug-eluting stent; Biodegradable polymer; Sirolimus; Orsiro;
Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study
Keywords: استنت سم زدایی; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; EES; everolimus eluting stent; ISA; incomplete stent apposition; LAISA; late acquired incomplete stent apposition; OCT; optical coherence tomography; PES; paclitaxel eluting stent; PCI; percutaneou
Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent
Keywords: استنت سم زدایی; Stent; Endothelialization; Healing; COBRA PzF stent; Polyzene-F; Stent; Endothalization; Guérison; COBRA PzF stent; Polyzène-F; BMS; bare-metal stent; CABG; coronary artery bypass graft; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; NSTEMI;
Comparison of mid-term clinical outcomes between “complete full-metal jacket strategy” versus “incomplete full-metal jacket strategy” for diffuse right coronary artery stenosis with drug-eluting stents
Keywords: استنت سم زدایی; Full metal jacket; Right coronary artery; Percutaneous coronary intervention; Drug-eluting stent;
Is a bare-metal stent still useful for improving the outcome of percutaneous coronary intervention? From the FU-Registry
Keywords: استنت سم زدایی; Bare-metal stent; Double-antiplatelet therapy; Drug-eluting stent; In-stent restenosis; Percutaneous coronary intervention;
Effect of over-2-year dual antiplatelet therapy on the rate of major adverse cardiac and cerebral events for everolimus-eluting stent implantation: The landmark analysis from Tokyo-MD PCI registry
Keywords: استنت سم زدایی; Drug-eluting stent; Dual antiplatelet therapy; Major adverse cardiac and cerebral events;
5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent
Keywords: استنت سم زدایی; drug-eluting stent; percutaneous coronary intervention; Resolute zotarolimus-eluting stent; stent thrombosis; ARC; Academic Research Consortium; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); MI; myocardial infarction; R-ZES; Resolute zotaro
Association of increased serum CTRP5 levels with in-stent restenosis after coronary drug-eluting stent implantation: CTRP5 promoting inflammation, migration and proliferation in vascular smooth muscle cells
Keywords: استنت سم زدایی; Percutaneous coronary intervention; Drug-eluting stent; Restenosis; C1q/TNF-related protein;
“Bringing on the light” in a complex clinical scenario: Optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry)
Keywords: استنت سم زدایی; OCT; optical coherence tomography; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; LMWH; low molecular weight heparin; NSTEMI; non ST-segment elevation myocardial infarction; PROTECT-OCT; Prospective Registry of Cancer Patients with Coronary Ste
Biomimetic apatite formed on cobalt-chromium alloy: A polymer-free carrier for drug eluting stent
Keywords: استنت سم زدایی; Drug-eluting stent; Polymer-free; Biomimetic apatite; Smooth muscle cell; Sirolimus;
Research paperCyclodextrin-based nanosponges for the targeted delivery of the anti-restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention
Keywords: استنت سم زدایی; β-Cyclodextrin; β-Cyclodextrin-based nanosponge; Cardiovascular diseases; Drug-eluting stent; 2-(3,4-Dimethoxyphenyl)-3-phenyl-4H-pyrido [1,2-a]pyrimidin-4-one.; β-Cyclodextrin (PubChem CID: 70702285); Diphenylcarbonate (PubChem CID: 7597); 2-(3,4-Dime
Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes
Keywords: استنت سم زدایی; diabetes; multivessel coronary artery disease; revascularization; survival; ACS; acute coronary syndrome(s); CABG; coronary artery bypass grafting; CAD; coronary artery disease; CI; confidence interval; DES; drug-eluting stent; DM; diabetes mellitus; HR;
miR-125a-5p Modulates Phenotypic Switch of Vascular Smooth Muscle Cells by Targeting ETS-1
Keywords: استنت سم زدایی; PCI; percutaneous coronary intervention; BMS; bare metal stent; ISR; in-stent restenosis; DES; drug-eluting stent; VSMC; vascular smooth muscle cell; EC; endothelial cell; ACTA2; alpha smooth muscle actin; MYH11; myosin heavy chain 11; miRNA; microRNA; FB
Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory?
Keywords: استنت سم زدایی; drug-eluting stent; dual antiplatelet therapy; high bleeding risk patients; in-stent restenosis; stent thrombogenicity; stent thrombosis; BA9; biolimus A9; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); EES; everoli
Assessing MICRO-vascular resistances via IMR to predict outcome in STEMI patients with multivessel disease undergoing primary PCI (AMICRO): Rationale and design of a prospective multicenter clinical trial
Keywords: استنت سم زدایی; PPCI; primary percutaneous coronary intervention; STEMI; ST-elevation myocardial infarction; IMR; index of microvascular resistances; MVD; multi-vessel disease; CHF; cardiac heart failure; ICD; intra-cardiac defibrillator; IRA; infarct-related artery; CAB
Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial
Keywords: استنت سم زدایی; Coronary artery disease; Drug-eluting stent; Percutaneous coronary intervention; Bioresorbable vascular scaffold;
Promus Premier versus Xience V and Taxus Liberte in contemporary United States practice (REWARDS premier registry)
Keywords: استنت سم زدایی; Drug-eluting stent; Stent thrombosis; Everolimus; Coronary artery disease;
One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent
Keywords: استنت سم زدایی; Endothelial progenitor cell; Diabetes mellitus; Drug-eluting stent; Percutaneous coronary intervention; Clinical outcomes;
Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS)
Keywords: استنت سم زدایی; In-stent restenosis; Drug-eluting stent; Bare-metal stent; Intravascular Ultrasound;
Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry
Keywords: استنت سم زدایی; ACS; acute coronary syndrome; ARC; Academic Research Consortium; BD-DES; biodurable polymer coated drug-eluting stent; BR-DES; bioresorbable polymer coated drug eluting stent; BMS; bare metal stent; CVA; cerebrovascular accidents; DEB; drug-eluting balloo
Restenosis after percutaneous coronary intervention for coronary chronic total occlusion. The central role of an optimized immediate post-procedural angiographic result
Keywords: استنت سم زدایی; Chronic total occlusion; Coronary occlusion; Drug-eluting stent; Percutaneous coronary intervention; Restenosis;
Protective effect of angiotensin II receptor blocker and calcium channel blocker on endothelial vasomotor function after everolimus-eluting stent implantation
Keywords: استنت سم زدایی; Angiotensin II receptor blocker; Drug-eluting stent; Endothelial function
ClinicalImpact of gender on long-term mortality in patients with unprotected left main disease: The Milan and New-Tokyo (MITO) Registry
Keywords: استنت سم زدایی; Unprotected left main coronary artery; Gender difference; Drug-eluting stent;
Intravascular ultrasound-guided drug-eluting stent implantation: An updated meta-analysis of randomized control trials and observational studies
Keywords: استنت سم زدایی; Intravascular ultrasound; Angiography; Drug-eluting stent; Meta-analysis;
Comparison of outcomes after everolimus-eluting stent implantation in diabetic versus non-diabetic patients in the Tokyo-MD PCI study
Keywords: استنت سم زدایی; Everolimus-eluting stent; Diabetes mellitus; Percutaneous coronary intervention; Drug-eluting stent
Impact of candesartan on cardiovascular events after drug-eluting stent implantation in patients with coronary artery disease: The 4C trial
Keywords: استنت سم زدایی; Percutaneous coronary intervention; Drug-eluting stent; Angiotensin II receptor blocker; Randomized controlled trial
ClinicalA randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudyâ
Keywords: استنت سم زدایی; Acute coronary syndrome; bioresorbable polymer; drug-eluting stent;
Impact of final kissing balloon inflation on vessel healing following drug-eluting stent implantation: Insight from the optical coherence tomography sub-study of the J-REVERSE trial
Keywords: استنت سم زدایی; Coronary bifurcation; Optical coherence tomography; Drug-eluting stent;
Resultados de los stents Resolute Integrity y Promus Element en el infarto de miocardio: análisis del ensayo aleatorizado DUTCH PEERS (TWENTE II)
Keywords: استنت سم زدایی; Intervención coronaria percutánea; Stent farmacoactivo; Infarto de miocardio; SÃndrome coronario agudo; Ensayo DUTCH PEERS (TWENTE II); Stent de platino-cromo liberador de everolimus; Stent de cobalto-cromo liberador de zotarolimus; Stent Promus Elemen
Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral Artery
Keywords: استنت سم زدایی; SFA; PAD; drug-coated balloon; drug-eluting stent
Are BVS suitable for ACS patients? Support from a large single center real live registry
Keywords: استنت سم زدایی; ACS; acute coronary syndrome; BMS; bare metal stent; BVS; bioresorbable vascular scaffold; BRS; bioresorbable scaffold; CABG; coronary artery bypass grafting; CAD; coronary artery disease; CEC; clinical events committee; DES; drug-eluting stent; ITT; inte
Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II)
Keywords: استنت سم زدایی; DES; drug-eluting stent; MACE; major adverse cardiac events; MI; myocardial infarction; PCI; percutaneous coronary intervention; POCE; patient-oriented clinical endpoint; TLF; target lesion failure; TLR; target lesion revascularization; TVF; target vessel
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome
Keywords: استنت سم زدایی; ACC; American College of Cardiology; ACS; acute coronary syndrome; AHA; American Heart Association; BMS; bare metal stent; CI; contraindication; CKD; chronic kidney disease; CTO; chronic total occlusion; DAPT; dual antiplatelet therapy; DES; drug-eluting
Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Keywords: استنت سم زدایی; acute coronary syndrome; clinical outcomes; stable angina; AF; atrial fibrillation; BMC2; Blue Cross Blue Shield of Michigan Cardiovascular Consortium; BMS; bare-metal stent; CAD; coronary artery disease; DES; drug-eluting stent; NSTEMI; non-ST-segment
Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine
Keywords: استنت سم زدایی; CLI; critical limb ischemia; DCB; drug-coated balloon; DES; drug-eluting stent; IQR; interquartile range; PAD; peripheral arterial disease; PTA; percutaneous transluminal angioplasty; SFA; superficial femoral artery; SMC; smooth muscle cell;
Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options
Keywords: استنت سم زدایی; ankle-brachial index; claudication; drug-eluting stents; endovascular therapy; exercise therapy; vascular diseases; BMS; bare-metal stent; CLI; critical limb ischemia; DAPT; dual-antiplatelet therapy; DCB; drug-coated balloon; DES; drug-eluting stent; MAC
Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold implantation in a real-world population: A single-center experience
Keywords: استنت سم زدایی; Bioresorbable vascular scaffold; Real-world; Clinical outcomes; Drug-eluting stent;
Hybrid Strategy for Long Diffuse Coronary Lesion
Keywords: استنت سم زدایی; bifurcation; bioresorbable vascular scaffold; drug-eluting stent; hybrid percutaneous coronary intervention;
Long-term clinical outcomes of drug-eluting stents in diabetic patients with small vessels compared to larger vessel—7 years clinical follow-up
Keywords: استنت سم زدایی; Diabetic; Small vessel; Drug-eluting stent; Outcomes
Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions: A patient-level pooled analysis of 5433 patients enrolled in contemporary coronary stent trials
Keywords: استنت سم زدایی; SYNTAX score; SYNTAX score II; Percutaneous coronary intervention; Drug-eluting stent; Risk stratification;
Bioresorbable Scaffolds Versus Metallic Drug-Eluting Stents
Keywords: استنت سم زدایی; bioresorbable scaffold; drug-eluting stent; percutaneous coronary interventions;
Rationale and design: Impact of intravascular ultrasound guidance on long-term clinical outcomes of everolimus-eluting stents in long coronary lesions
Keywords: استنت سم زدایی; Drug-eluting stent; Intravascular ultrasound; Coronary artery disease
Everolimus-eluting stent versus bare-metal stent in elderly (⥠75 years) versus non-elderly (< 75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the examination trial
Keywords: استنت سم زدایی; Myocardial infarction; Elderly; Drug-eluting stent; Outcome;
Impact of the learning curve on procedural results and acute outcome after percutaneous coronary interventions with everolimus-eluting bioresorbable scaffolds in an all-comers population
Keywords: استنت سم زدایی; BVS; bioresorbable vascular scaffold; DES; drug-eluting stent; IVUS; intravascular ultrasound; MACE; major adverse cardiac event; OCT; optical coherence tomography; PLLA; poly-L-lactic acid; SD; standard deviation; TLR; target lesion revascularization; TV
Gestion du risque et stent actif. Ãvaluation régionale des pratiques professionnelles en cardiologie interventionnelle
Keywords: استنت سم زدایی; Ãvaluation des pratiques professionnelles; Cardiologie interventionnelle; Stent actif; Gestion du risque; Audit; Practice assessment; Interventional cardiology; Drug-eluting stent;